Dr. Francesca Ferraro, MD

Dr. Ferraro practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Ferraro's NPI, 1295173136, was assigned on June 13, 2013. Dr. Ferraro holds Missouri license 2016041356.

Dr. Ferraro's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Ferraro also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Ferraro's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Ferraro to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ferraro practices. Vendor and product names are available with a free account.

Medical oncology is Dr. Ferraro's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Ferraro is licensed in Missouri.

CMS data shows 220 Medicare services from Dr. Ferraro across 2 procedure codes in 2024, for 45 Medicare patients. Medicare paid $14,434 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 45 Medicare patients who saw Dr. Ferraro in 2024. The largest group is 65 to 74, with 28 patients. 75% of them have high blood pressure, and 69% have high cholesterol. Their average risk score is 3.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ferraro's median patient age at 70, with 28% women.

In 2016, Dr. Ferraro wrote 49 Medicare Part D claims. Every claim was for a generic drug. They cover 4 drugs, with $771 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Ferraro for performance year 2024, reported as part of a group. Dr. Ferraro accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 29 papers to Dr. Ferraro, published from 2010 to 2024. 2023 was the busiest year, with 4. The most frequent topics are Leukemia, Myeloid, Acute, Bone Marrow Cells and Cell Line, Tumor. Dr. Ferraro has published most often in Clin Cancer Res. Dr. Ferraro's most frequent co-authors are Timothy J. Ley, MD, Daniel C. Link, MD and Rushdia Z. Yusuf, MD.

Dmand AI links Dr. Ferraro to 3 clinical trials, 2 of them phase 1 studies. 1 is still active or recruiting. Conditions studied include Myelodysplastic Syndromes, Graft vs Host Disease and Hodgkin Disease. Washington University School of Medicine sponsors the most, 3.

CMS Open Payments shows 8 general payments to Dr. Ferraro from 8 drug and device companies from 2017 to 2023. Food and beverage make up the largest share, 57% of the total. Merck Sharp & Dohme Corporation paid the most, $134.